about
To use or not to use: an update on licit and illicit ketamine usePossible pathophysiology of ketamine-related cystitis and associated treatment strategiesKetamine: 50 Years of Modulating the Mind'Special k' and a loss of cell-to-cell adhesion in proximal tubule-derived epithelial cells: modulation of the adherens junction complex by ketamineKetamine for chronic pain: risks and benefits.Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice.Effects of long-term ketamine administration on rat bladder protein levels: a proteomic investigation using two-dimensional difference gel electrophoresis system.Biological effect of ketamine in urothelial cell lines and global gene expression analysis in the bladders of ketamine‑injected mice.The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine useKetamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum.Illicit ketamine and its bladder consequences: is it irreversible?Microvascular Injury in Ketamine-Induced Bladder Dysfunction.The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.Evaluation of urinary bladder fibrogenesis in a mouse model of long-term ketamine injectionKetamine-associated ulcerative cystitis: a case report and literature review.Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.Ketamine: an update on its abuse.Nephrotoxic effects of designer drugs: synthetic is not better!Ketamine and international regulations.Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment.A REVIEW OF KETAMINE ABUSE AND DIVERSION.Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.Ketamine-Induced Uropathy: A New Clinical Entity Causing Lower Urinary Tract Symptoms.Is Urodynamic Study a Good Witness to the Progression of Ketamine-Associated Cystitis?Changes to the bladder epithelial barrier are associated with ketamine-induced cystitis.Mast cells infiltration and decreased E-cadherin expression in ketamine-induced cystitis.Nerve hyperplasia: a unique feature of ketamine cystitis.Bilateral hydronephrosis and cystitis resulting from chronic ketamine abuse.Ketamine-induced cholangiopathy: a case report.Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study.Augmentation enterocystoplasty is effective in relieving refractory ketamine-related bladder pain.Treatment of ketamine-associated cystitis with chondroitin sulphate.The Immunomodulatory Imbalance in Patients with Ketamine Cystitis.Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1.The effects of recreational ketamine cystitis on urinary tract reconstruction - a surgical challenge.The fibrosis of ketamine, a noncompetitive N-methyl-d-aspartic acid receptor antagonist dose-dependent change in a ketamine-induced cystitis rat model.Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.A pilot study of urine cytokines in ketamine-associated lower urinary tract symptoms.Ketamine cystitis: practical considerations in management.
P2860
Q24634006-2A7C02B0-B59E-465A-B63A-2E9AE8D7B441Q27013111-49BD7197-6DB7-4881-95E0-587CCB5415A9Q28077524-BA77C25F-A5AF-4CC9-B393-F96D4F307949Q28535969-0CFD94C9-D901-4F98-913A-E90A1182E7D1Q33582045-268F3638-9F81-43B7-AB84-7065C24DC3D3Q34030028-85B12CE9-60FD-48A0-BC65-AA581A1D170EQ34407467-2B0F60A3-5E8A-4239-91F4-E4B71A038CBFQ34573628-1767C6CE-40E9-4064-9E88-C4C5A79018B3Q34673343-7EBA78D6-0A98-43B0-ABFE-749B5F529379Q35200052-5B96285E-B99C-4E10-BC87-BE7B2CD4C82EQ35673638-DB658059-F81A-4CEB-9E38-AF79BBC3F135Q35980253-F9BCEA36-F491-4672-89F5-E76B51B300C6Q36105036-272A16F4-20DE-497D-B641-B67B719DE5E1Q36369872-7F2ABD1B-84F3-4F82-ABB9-3EA8E9DDCB0BQ37190860-EEA72B00-78AD-4F5D-824B-0D36F3BCFF5AQ37963862-CE82CAAB-D658-473D-98E5-47C64122ADC4Q38105535-A06DD6F6-84A5-4877-A959-50B1AB6DCCEDQ38197894-0B11BB74-028D-4B98-950E-5BF178F11F89Q38198873-53165B0E-E806-4CB1-BF46-B6A84DB9C317Q38370198-8C26B812-C181-47B1-8EF1-F09A72E712F6Q38709399-EF9955C6-C03C-425B-A152-DAAA17FA13BDQ38872263-591A30A8-33E3-489B-B1F9-0D03BBD3302BQ39246120-C567639E-606A-4249-9386-FDDB05453DCAQ39253963-6AE4CB51-DDE8-4E2F-976C-EFC5D4E769DCQ40215608-EA6FBDF6-05C3-424D-BBF2-2A852C5C6606Q41665026-5EA771A6-AB67-48E4-9002-C2F22280CFC9Q41680745-687B57CA-46FB-40B5-8B27-5BA49F2D3665Q41874803-FE1599A7-1D7A-439A-8E3E-FE5B14F71E08Q42023427-6F9CA462-36AA-4ACC-BCEC-B2472CA2B1F0Q42741033-2083CF77-9E40-4B70-8397-2D5BB21D7073Q43046156-9BF5A0E0-0093-4247-99A6-9C330027D33EQ44302495-E7BA4684-90FD-4D2E-A310-E687D0660217Q44375500-7E1465CE-B3D2-451D-BF61-04D9EF2A98ECQ47160503-204D5B82-96CC-4365-8143-1FF279046B17Q47316195-4C4C22A9-B6AD-4F95-A123-896D03782D3BQ47325469-B467482E-78BD-4E60-BE78-7A715F9F8EE4Q47657800-5F0FB3A4-84D6-485A-96F8-FB2E8B3A9939Q47798424-8B9FF8BC-D6D3-49B9-A3EB-E5F08EED38FEQ47851196-25A6EE0C-03BB-42C9-9398-41E59A79F728Q47877869-085C4A4E-1C75-4BE4-BDF8-D7900550D111
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Ketamine-associated bladder dysfunction.
@en
Ketamine-associated bladder dysfunction.
@nl
type
label
Ketamine-associated bladder dysfunction.
@en
Ketamine-associated bladder dysfunction.
@nl
prefLabel
Ketamine-associated bladder dysfunction.
@en
Ketamine-associated bladder dysfunction.
@nl
P2093
P1476
Ketamine-associated bladder dysfunction.
@en
P2093
Chang-Min Lin
Chih-Wei Tsao
Dah-Shyong Yu
Feng-Pin Chuang
Guang-Huan Sun
Sheng-Tang Wu
Shou-Hung Tang
Sun-Yran Chang
Tai-Lung Cha
Tsung-Hsun Tsai
P304
P356
10.1111/J.1442-2042.2009.02361.X
P577
2009-07-29T00:00:00Z